Cargando…
BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052909/ https://www.ncbi.nlm.nih.gov/pubmed/35045695 http://dx.doi.org/10.3324/haematol.2021.280337 |
_version_ | 1784696883161071616 |
---|---|
author | Abdul-Jawad, Sultan Beatson, Richard Lechmere, Thomas Graham, Rosalind Alaguthurai, Thanussuyah Graham, Carl Vidler, Jennifer Kulasekararaj, Austin Patten, Piers EM Doores, Katie J Irshad, Sheeba |
author_facet | Abdul-Jawad, Sultan Beatson, Richard Lechmere, Thomas Graham, Rosalind Alaguthurai, Thanussuyah Graham, Carl Vidler, Jennifer Kulasekararaj, Austin Patten, Piers EM Doores, Katie J Irshad, Sheeba |
author_sort | Abdul-Jawad, Sultan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9052909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-90529092022-05-13 BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes Abdul-Jawad, Sultan Beatson, Richard Lechmere, Thomas Graham, Rosalind Alaguthurai, Thanussuyah Graham, Carl Vidler, Jennifer Kulasekararaj, Austin Patten, Piers EM Doores, Katie J Irshad, Sheeba Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-01-20 /pmc/articles/PMC9052909/ /pubmed/35045695 http://dx.doi.org/10.3324/haematol.2021.280337 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Abdul-Jawad, Sultan Beatson, Richard Lechmere, Thomas Graham, Rosalind Alaguthurai, Thanussuyah Graham, Carl Vidler, Jennifer Kulasekararaj, Austin Patten, Piers EM Doores, Katie J Irshad, Sheeba BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title | BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title_full | BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title_fullStr | BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title_full_unstemmed | BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title_short | BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes |
title_sort | bnt162b2 covid-19 and chadox1 ncov-19 vaccination in patients with myelodysplastic syndromes |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052909/ https://www.ncbi.nlm.nih.gov/pubmed/35045695 http://dx.doi.org/10.3324/haematol.2021.280337 |
work_keys_str_mv | AT abduljawadsultan bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT beatsonrichard bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT lechmerethomas bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT grahamrosalind bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT alaguthuraithanussuyah bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT grahamcarl bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT vidlerjennifer bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT kulasekararajaustin bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT pattenpiersem bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT dooreskatiej bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes AT irshadsheeba bnt162b2covid19andchadox1ncov19vaccinationinpatientswithmyelodysplasticsyndromes |